Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer

Histone deacetylase inhibitors (HDACs) are known to exhibit antiproliferative effects on various carcinoma cells. In this study, the in vivo efficiency of two HDACs, sodium butyrate and tributyrin, on prostate cancer growth inhibition were investigated. To gain an insight into the possible underlyin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuefer, R, Hofer, M D, Altug, V, Zorn, C, Genze, F, Kunzi-Rapp, K, Hautmann, R E, Gschwend, J E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409572/
https://www.ncbi.nlm.nih.gov/pubmed/14735205
http://dx.doi.org/10.1038/sj.bjc.6601510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409572/
https://www.ncbi.nlm.nih.gov/pubmed/14735205
http://dx.doi.org/10.1038/sj.bjc.6601510

Ejemplares similares